🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10245+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10245 recruiting trials

NARecruitingNCT07271225

Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting

🏥 Indonesia University📍 1 site📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07245238

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

🏥 Khon Kaen University📍 1 site📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT07399821

An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma

🏥 Princess Maxima Center for Pediatric Oncology📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07293923

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

👨‍⚕️ Yelena Lalazar, Magenta Medical📍 5 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07189403

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

🏥 Daiichi Sankyo📍 6 sites📅 Started Nov 2025View details ↗
EARLY_Phase 1RecruitingNCT07339540

the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases

🏥 Tongji Hospital📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07216105

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

👨‍⚕️ Brian Dempster, Fate Therapeutics📍 3 sites📅 Started Nov 2025View details ↗
NARecruitingNCT06735560

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN

🏥 Nantes University Hospital📍 2 sites📅 Started Nov 2025View details ↗
Phase 2Enrolling by InvitationNCT06723015

Tau PET Outcomes With Anti-amyloid Immunotherapies

👨‍⚕️ Petrice Cogswell, M.D., Ph.D., Mayo Clinic📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT06732284

Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task

👨‍⚕️ Elisa EVANGELISTA, CHU de Nimes📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07121413

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

🏥 Shanghai Synvida Biotechnology Co.,Ltd.📍 12 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07223424

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

👨‍⚕️ Diwakar J Davar, MD, UPMC Hillman Cancer Center📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07347314

Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy

🏥 National Cancer Center, Japan📍 3 sites📅 Started Nov 2025View details ↗
RecruitingNCT07345988

Human Babesiosis in Metropolitan France

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT06066138

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

👨‍⚕️ James L Gulley, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07108153

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

👨‍⚕️ Medical Director, Sionna Therapeutics Inc.📍 13 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06567717

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

👨‍⚕️ Tanzira Zaman, MD, Cedars-Sinai📍 1 site📅 Started Nov 2025View details ↗
Enrolling by InvitationNCT07250984

Treatment of Atypical Resistant Facial Pain

🏥 Alenka Spindler-Vesel📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT06930846

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

👨‍⚕️ Elaine T Kiriakopoulos, MD, MPH, MSc, Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07203001

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

🏥 Novartis Pharmaceuticals📍 22 sites📅 Started Nov 2025View details ↗
← PreviousPage 48 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →